Responses
Clinical and epidemiological research
Concise report
Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.